Clinical guidelines for sex-differentiated care
A phased Nordic priority sequence — cardiovascular disease in women first, menopause continuity second, sex-disaggregated reporting in all guidelines.
PolicyPhase 1 integrates female-specific CVD risk factors (pregnancy complications, PCOS, premature menopause) into Nordic risk tools — enhancing FINRISK, NORRISK2, and SCORE2. The Guideline Council holds a permanent seat on the Catalytic Fund Steering Committee, closing the loop between clinical need and research investment.
Transformation
From
National clinical guideline activity has been exceptional across four Nordic countries in 2025–2026, yet no Nordic country has a sex-differentiated national clinical guideline for cardiovascular disease in women, and no Nordic national authority has adopted the 2026 ACOG endometriosis guideline (clinical diagnosis on symptoms, first-line imaging without mandatory laparoscopy)
To
A phased Nordic priority sequence — cardiovascular disease in women first, menopause continuity second, ACOG-aligned endometriosis third — entering through the Norwegian Directorate of Health's March 2024 self-named gap (NKTEA as the endometriosis vehicle), coordinated through the NFOG translation initiative
Description
National clinical guideline development on sex-differentiated care would integrate sex-differentiated diagnostic and treatment recommendations into Nordic practice through national health authority publication. National clinical guideline activity has been exceptional across four Nordic countries in 2025 and 2026, yet no Nordic country has a sex-differentiated national clinical guideline for cardiovascular disease in women, and no Nordic national authority has formally adopted the 2026 ACOG endometriosis guideline endorsing clinical diagnosis on symptoms and first-line imaging without mandatory laparoscopy. The guideline factory is running, but two of the most consequential international clinical evidence shifts have not entered Nordic guidance.
A phased Nordic priority sequence would let Nordic women’s care move from leading on menopause to leading on the full disease burden pattern: cardiovascular disease in women first, menopause continuity second, and an ACOG-aligned endometriosis update third. The cleanest entry point is the Norwegian Directorate of Health’s March 2024 self-named gap, which identifies the absence of a national endometriosis guideline and names NKTEA as the vehicle to develop one. Coordination through the NFOG translation initiative and the five national authorities is already available.
The supporting evidence is already accessible to the Nordics, including the 2024 Journal of the American Heart Association meta-analysis of 1.06 million women, finding an odds ratio of 2.50 for myocardial infarction in PCOS, and the 2019 High-STEACS sex-specific troponin threshold analysis. Socialstyrelsen, Sundhedsstyrelsen, Helsedirektoratet, Duodecim, Landlæknir, NFOG, and NKTEA are positioned to coordinate it.
Evidence anchors
At a glance
- Natural lead
- Socialstyrelsen, Sundhedsstyrelsen, Helsedirektoratet, Duodecim, Landlæknir, NFOG, and NKTEA
- Indicative investment
- €5–8M across phases
Entry points
- NordicNCM mandates and funds; NFOG provides specialist content
- NationalHealth directorates adopt (rotating secretariat: SE→DK→NO)
- RegionalHospitals implement guidelines; track compliance
Indicators
Output
- CVD Task Force established; Phase 1 guidelines drafted
- Menopause and Pain guidelines published
- Living Guideline Platform operational
Handoff
- Guidelines available as digital decision support
- EHR integration in pilot regions
- All Nordic EHR systems integrated
Outcome
- Clinicians access women-specific CVD risk tools
- Diagnostic delays reduced in pilot pathways
Building on
Nordic foundations
International inspirations
Connected needs
Cite this need
Cite this need
Persson, J. (2026). C-Po-1 Clinical guidelines for sex-differentiated care. In The Nordic Implementation Playbook for Women's Health 2040. CIFS. https://womenshealth2040.org/playbook#c-po-1